Testing version — LOERadar is in active testing. Features and data may change.

POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE) | LOERadar

Viewing data from:

POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER

NDA

CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | N019367 | BAXTER HEALTHCARE CORP

8 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

7 letters from Drugs@FDA

Date	Submission	Document
Nov 6, 2025	SUPPL -42	View Letter (PDF)
Oct 10, 2019	SUPPL -36	View Letter (PDF)
Dec 7, 2017	SUPPL -30	View Letter (PDF)
Oct 24, 2011	SUPPL -26	View Letter (PDF)
Aug 31, 2005	SUPPL -22	View Letter (PDF)
Jun 8, 2005	SUPPL -21	View Letter (PDF)
Jan 3, 2003	SUPPL -15	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (8)

Sort:

#002 — 20MG/100ML;5GM/100ML;105MG/100ML;600MG/100ML;310MG/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 5, 1985

#003 — 20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 5, 1985

#006 — 20MG/100ML;5GM/100ML;254MG/100ML;600MG/100ML;310MG/100ML

AP

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 5, 1985

#004 — 20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML

AP

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 5, 1985

#005 — 20MG/100ML;5GM/100ML;328MG/100ML;600MG/100ML;310MG/100ML

AP

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 5, 1985

#007 — 20MG/100ML;5GM/100ML;254MG/100ML;600MG/100ML;310MG/100ML

AP

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 5, 1985

#008 — 20MG/100ML;5GM/100ML;328MG/100ML;600MG/100ML;310MG/100ML

AP

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 5, 1985

#001 — 20MG/100ML;5GM/100ML;105MG/100ML;600MG/100ML;310MG/100ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Apr 5, 1985

No patent or exclusivity listings for this strength.